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Spa efficacy in relation to pathophysiological
characteristics of bronchial asthma.
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Abstract: The number of patients with respiratory disease in the elderly has been
increasing in recent years. Pathophysiological characteristic of respiratory diseases in
older patients is clearly different from that in younger patients. In this study,
rehabilitation for patients with respiratory disease, particularly bronchial asthma, in
the elderly was discussed in relation to pathophysiology of asthma. Complex spa
therapy has two kinds of actions, direct and indirect actions. Subjective and objective
symptoms of patients with asthma are improved by spa therapy for 1 - 2 months,
accompanied with improvement of ventilatory function, and decrease in bronchial
hyperresponsiveness and respiratory resistance. In addition to these direct action of spa
therapy, increase in strength of respiratory muscle, stability of autonomic nerve
syetem, psychical relaxation, and inprovement of suppressed function of adrenocortical
glands are observed as indirect action of spa therapy. Regarding clinical asthma type
classified by pathophysiological changes of the airways, spa therapy was more
effective in patients with hypersecretion and bronchiolar obstruction. These results
suggest that complex spa therapy is available as rehabilitation and/or treatment for
patients with respiratory disease.
Key words: bronchial asthma, rehabilitation, complex spa therapy, ventilatory
function, adrenocortical glands
Introduction
Rehabilitation for patients with respIra-
tory disease has been noticed in recent years.
Pulmonary rehabilitation is a multidimen-
sional continuum of services directed to
persons with pulmonary disease and their
families, usually by an interdisciplinary team
of specialists, with the goal of achieving and
maintaining the individual's maximum level
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Fig. 2. Nnmber of patients with respiratory
disease who had spa therapy at our
hospital and their resident areas
(prefectures) in 1995
diseases were admitted at our hospital. Of
the 125 patients, 112 (89.6%) were patients
with chronic obstructive pulmonary disease
(COPD) (91 with bronchial asthma, 4 with
chronic bronchitis, 7 with obstructive bron-
chiolitis, and 10 with pulmonary emphy-
sema). Larger number of patients was admit-
ted from Hyogo, Osaka, Okayama, and
Yamaguchi prefectures (Fig. 2).
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Regarding the distribution of patient age,
the number of patients over the age of 70
was largest in patients inside Tottori prefec-
ture. In contrast, the number of patients
between the ages of 50 and 59, and between
60 and 69 was Iaeger in patients from distant
areas (Fig. 3). The frequency of bronchial
asthma was predominantly larger among
various respiratory diseases in patients inside
Tottori prefecture (60.7%) and outside
Tottori prefecture (82.3%)(Fig. 4).
Fig. 1. Number of patients with bronchial
asthma (e) and those from dis-
tant areas (prefectures other than
Tottori) (0) admitted to Misasa
Branch Hospital over the last 15
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Asthma patients from distant areas
The number of patients with asthma from
distant areas outside Tottori prefecture, who
have been admitted at our hospital has been
increasing in recent years 31 , as shown in Fig.
1. In 1995, 125 patients with respiratory
of independence and functioning III the
community I l. The program for pulmonary
rehabilitation is intended in sequence : pa-
tient selection, intial evaluation, identify
goal, components of a comprehensive care
program, continuing assessment, repeat eval-
uation at conclusion and discharge from
program. The treatment schedule comprises
general treatment, medications, respiratory
therapy, and rehabilitation medicine (chest
physiotherapy, exercise reconditioning, occu-
pational therapy, psychosocial rehabilitation,
and vocational rehabilitation 2 l.
In this study, rehabilitation using hot
spring for patients with asthma was dis-
cussed III relation to direct and indirect
actions of spa therapy.
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Fig. 3. Age of patients with respiratory
disease in Tottori prefecture ( m )
and from distant areas ( ~ ) in
1995
asthma bring about osteoporosis, muscle
weakness, and suppression of immunity which
easily induces common cold and/or respira-
tory infection. Furthermore, limitation of
exercise produces suppresses mental activity
(Fig. 5). Adequate exercise is important in
treatment for asthma to avoid suppression of
immunity, osteoporosis and muscle weakness
and to keep mental condition active.
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Fig. 5. Problems III treatment for asthma
Pathophysiology of the airways in asthma
Fig. 4. Respiratory diseases and number of
patients inside Tottori prefecture
( Im1 ) and those from distant
areas (outside Tottori prefecture)
( R2I ) in 1995
Problems in treatment for asthma
Limitation of exercise is often required III
treatment for asthma to avoid exerClse-
induced bronchospasm and overload on heart
stimulated with bronchodilators. Limitation
of exercise and long-term systemic admin-
istration of glucocorticoids for intractable
Inflammation has been noted as the com-
mon pathophysiological changes in the air-
ways of asthma. In inflammatory process
various blood cells such as lymphocytes',5),
eosinophils 6 .7), and neutrophils migrate into
allergic reaction site. Among these cells.
activated T lymphocytes and eosinophils main-
ly participate in onset mechanisms of asth-
ma 6-11). However, recent reports have sug-
gested that neutrophils also play an impor-
tant roles III induction of asthma attacksl2, 13).
Asthma IS classified into three types ac-
cording to cellular composition in the air-
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ways: type I a, type I b and type II. Type
I a is divided into two subtypes according to
the amount of expectoration; 0 ~ 49m£ / day
(type I a - 1 ) and 50 -99m£/day (type I a-
2 )'HI) (Table 1). The age when the symp-
toms of each asthma type begin is different
closely related to airway inflammation. The
mean proportion of neutrophils III bron-
choalveolar lavage (BAL) fluid in patients
with type II asthma is significantly larger
than that in patients with type I a - 1
(p<O.OO1), type I a -2 (p, 0<001), and type
I b (p<O.OO1)(Fig. 7).
Fig. 6. Relationship between clinical asthma
types and patient age
Table 1. Asthma classification by clinical
symptoms and signs
among the asthma types. The symptoms
start to occur in their 20's in types I a - 1
and I a - 2, in their 30's in type I b and in
their 40's in type II asthma patients (Fig.
6 ) 21). These clinical types of asthma are
Proportion of BAL neutrophils III
each clinical asthma type. Vertical
columns represent the mean for
each group
Fig. 7 .
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However, recent studies have shown that
there are some type II asthma patients
without BAL neutrophilia22. 23). Furthermore,
type II asthma is characterized by predomi-
nant dysfunction of ventilation. The mean
value of FEV 1.0% in patients with type II
is significantly lower than that in asthma
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Clinical symptoms and signs
20 30 4010o
Type
la. Simple broncho- Patients with symptoms such as
constriction wheezing and dyspnea which are
mainly elicited by broncho-
constriction
This type is divided into two
subtypes according to the
amount of expectoration
la-l : 0-49 ml/day
la-2: 50-99 ml/day
lb. Brobchoconstriction Patients with symptoms due to
+ hypersecretion hypersecretion (more than 100
mil day). in addition to broncho-
constriction
II. Bronchiolar Patients with symptoms mainly
obstruction eliCited by bronchiolar obstruction
Ia-2
Ia-l
Ib
JI
Asthma
type
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Fig. 8. FEV1.0% value in each clinical
asthma type. Vertical columns rep-
resent the mean for each group
type I a-I (p<O.OO1), type I a- 2 (p<0.02),
and type I b (p.<O.01)(Fig. 8).
The value of V25 in patients with type II is
also significantly smaller than that In
asthma type I a-I (p<O.OO1), type I a-2
(p<0.02), and type I b (p<O.01) (Fig. 9)21).
In contrast, hypersecretion in the airways
is closely related to BAL eosinophilia. The
mean proportion of BAL eosinophils in pa-
tients with type I b is significantly higher
than that in asthma type I a-I (p<O.OO1),
type I a - 2 (p<0.02), and type II (p<O.OO1).
The mean proportion of BAL eosinophils is
also significantly larger in patients with
type I a - 2 than in those with type I a-
1 (p<O.OO1) (Fig. 10)21,24).
Spa therapy has two kinds of action mech-
anisms : direct and indirect actions. Improve-
.
Fig. 9. %V25 value in each clinical asthma
type. Vertical columns represent the
mean for each group
ment of subjective and objective symptoms25- SIl
and ventilatory function 32- 35), decrease in air-
way resistance, and improvement of bronchial
hyperresponsiveness36. m are observed as direct
action of spa therapy. In contrast, increase
in strength of respiratory muscle, stability of
autonomic nerve system:l8), psychical relaxa-
tion, and improvement of suppressed ad-
renocortical glands39- 41) are found as indirect
action of spa therapy (Table 2).
Regarding ventilatory function, spa therapy
improves low value of forced vital capacity
(FVC), as well as low values of FEV 1.0,
. .
Vso and V25, in patients with asthma. In-
crease in low value of FVC by spa thrapy is
significant in all age groups of asthma pa-
tients, but not in those over the age of 70
(Fig. 11). The increase of FVC after spa
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Fig. 11. Improvement of FVC by spa therapy
in patients with asthma in relation
to age. a, p<0.05, b, p<0.05. B
before and A ; after spa therapy
therapy is also significant in patients with
types la-l, la-2, and lb, compared to
the initial values, however, the increase is
not significant in patients with type II asth-
ma (Fig. 12)34). Bronchial hyperresponsiveness
is also suppressed by spa therapy:J6). The
action of spa therapy is speculated to be
related to clinical effects of the therapy (Fig.
13).
The function of adrenocortical glands is
often suppressed in patients with long-term
systemic glucocorticoid therapy. Spa therapy
improves suppressed function of adren-
ocortical glands3'J-41l. Serum cortisol levels
significantly Increase after spa therapy,
compared with the initial levels before the
therapy, in all age groups except the group
over age 70 of asthma patients (Fig. 14).
The increase in serum cortisol levels is more
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objective symptoms
Improvement of ventilatory
function
Decrease in airway resistance
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Improvement of adrenocortical glands
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Fig. 10. Proportion of BAL eosinophils In
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Table 2. Action mechanisms of spa therapy
on bronchial asthma
20-39 40-49 50-59 60-69 70+
Patient age (years)
Serum cortisol levels before (.)
and after spa therapy (~) and
patient age. a and c ; p<O.OOI, b
and d ; p<O.05
Before After Before After Before After
ISpa therapy I
6
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Fig. 15. Changes in serum cortisol levels
before and after spa therapy III
patients with bronchial asthma.
*p<O.05, **p<O.Ol.
predominant in patients with lower levels of
serum cortisol before the therapy. Five of 7
patients with levels less than 5.0mcg/ dP
showed predominant increase after spa ther-
apy (Fig. 15). With the increase in serum
cortisol levels by spa therapy, the dose of
glucocorticoids used to control asthma at-
tacks can be reduced, accompanied with im-
provement of clinical symptoms (Table 3).
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Before
Spa therapy
Decrease of Bronchial reactivity
after spa therapy in patients with
bronchial asthma. Vertical columns
represent the mean of subjects
before and after spa therapy
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Asthma type
Improvement of FVC by spa therapy
in patients with asthma classified
by clinical symptoms. B ; before spa
therapy, A; after spa therapy. a,
p<O.OOI, b,p<O.02, c,p<O.OI
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Fig. 16. Evaluation of spa effects by a CMI
method in patients with bronchial
asthma before (B) and after the
therapy (A)
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Table 3. Improvement of symptoms by spa
80
therapy in each asthma type
70
Asthma No of Reduction of Improvement of 60
type patients prednisolone symptoms
50
la-1 9 5/9(55.6%) 6/9(66.7%) 40
la-2 8 7/8(87.5%) 8/8(100%) 30
20
Ib 7 4/7(57.1%) 7/7(100%)
10
II 9 4/9(44.4%) 6/9(66.7%) 0
The increase in serum cortisol levels is closely
related to the effects of spa therapy. The
levels were significantly increased after spa
therapy in patients with marked and moder-
ate efficacy of the therapy (Table 4).
Fig. 17. Evaluation of spa effects by a SDS
method in patients with bronchial
asthma
had depressive mental state. The mean point
decreased from 42.9 to 40.7 by spa therapy
(Fig. 17). In Comprehensive Asthma Inven-
tory (CAr), categories of mental state, ex-
tent of conditioning, suggestion, fear of
expectation, dependency, frustration a~d
flight into illness, were clearly improved by
spa therapy (Fig. 18-1, 2).
Table 4. Serum cortisol levels and spa effi-
cacy
No of Serum cortisol levels (mcg/dl)
Efficacy patients Before After spa therapy
Marked 10 2.6 ± 1.4a 10.0 + 2.8 a
Moderate 27 2.9 ± 1.6 b 6.2 ± 2.6b
Slight 7 2.3 ± 1.2 3.4 ± 2.2
No 2 4.0 ± 0.2 3.1 ± 2.3
a;p<0.001, b;p<0.001
Spa therapy has effects on psychological
factors in patients with asthma421• In Cornell
Medical Index (CMr), the mean point of
physical symptoms decreased from 37.7 be-
fore spa therapy to 29.7 after the therapy.
The mean improvement rate was observed in
90.0% of respiratory symptoms, 66.7% of
CIJ symptoms, and 46.7% of psychical symp-
toms (Fig. 16). In Selffrating Depression
Scale (SDS), many patients, who were admit-
ted at our hospital for having spa therapy,
showed more than 40, suggesting that they
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Clinical effects of spa therapy
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Fig. 19. Improvement of bronchial sensitivity
by spa therapy in patients with
asthma. a : p<O.Ol, b : p<0.02
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Spa therapy
by long-term systemic administration of glu-
cocorticoids43- 45J , leading to difficulty of the
treatment for asthma. The efficacy of spa
therapy is different between younger and
older patients with asthma. Spa therapy is
more effective in patients over the age of 60
than in those between the ages of 20 and 59.
Bronchial hyperresponsiveness IS signifi-
cantly improved both in younger and older
patients by spa therapy (Fig. 19). The bron-
chial reactivity of atopic asthma is stronger
in patients without spa effects than in those
with spa efficacy, however, the reactivity is
not different between effective and none-
ffective subjects in nonatopic asthma (Fig.
20). Furthermore the efficacy of spa therapy
is not same among clinical asthma types.
Spa therapy is more effective in type I b46J
and type II 23.28) than in type I a47J• These re-
sults suggest that clinical asthma types and
patients age should be considered to obtain
enough effects of spa therapy in treatment
for asthma.
B A B A
Decreased Score
motivation
towards
therapy
B A B A
Distorted Negative
Ii f e attitudes
towards
prognosis
B A
Flight
into
illness
Fig. 18-1. Evaluation of spa effects by a
CAl method in patients with
bronchial asthma before (B) and
after the therapy (A)
Our previous studies have shown that spa
therapy is effective in patients with bronchial
asthma, particularly in patients with steroid-
dependent intractable asthma (SDIA)'" 41). In
SDIA, airway inflammation including in-
flammatory cells and, chemical mediators
and cytokines from these celles are affected
Fig. 18-2. Evaluation of spa effects by a
CAl method in patients with
bronchial asthma before (B) and
after the therapy
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呼吸器疾患のリハビリテーション.気管支噂息の
病態的特徴と関連した温泉療法の効果
谷崎勝朗,御船尚志,光延文裕,保崎泰弘,
芦田耕三,柘野浩史,岡本 誠,岩垣尚志,
山本和彦
岡山大学医学部附属病院三朝分院内科
近年老年者の呼吸器疾患が増加しつつある｡老
年者の呼吸器疾患の病態的特徴は若年者のそれと
は明らかに異なっている｡本論文では,老年者の
呼吸器疾患,なかでも気管支喋息に対する温泉療
法を中心としたリ-ビリテ-ションについて,そ
の病態的特徴と関連して若干の知見を述べる｡
複合温泉療法は2つの作用,すなわち直接作
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用と間接作用を有している｡患者の白,他覚症状
は1-2カ月の温泉療法により明らかに改善傾向
を示すが,同時に,換気機能の改善,気道過敏性
や気道抵抗の低下が観察される｡これらの温泉療
法の直接作用のはか,呼吸筋の増強,自律神経系
の安定化,精神的リラックス,低下した副腎皮質
機能の改善,などの間接作用も観察される｡気道
の病態生理的特徴より分類した瑞息の臨床病型に
関しては,過分泌や細気管支閉塞を伴うような病
型に対して,温泉療法は有効性が高い｡これらの
結果は,複合温泉療法が呼吸器疾患の治療ないし
リハビリテーションとして有用であることを示し
ている｡
辛-ワード:気管支嘱息,リ-ビリテ-ション,
複合温泉療法,換気機能,副腎皮質
